Paxene
information and resources from the National Cancer Institute
paclitaxel
treatment of advanced AIDS-related Kaposi's sarcoma after failure of first line or subsequent systemic chemotherapy
Baker Norton Pharmaceuticals, Inc Dec 24 1997
|
|
|
|
news articles
IVAX Reports 3rd Quarter 2005 Results; Revenues up 41% to Record ... Nov 8, 2005
Genetic Engineering News, ...to recognition in this quarter of the previously disclosed deferred revenues from our licensing agreement with Mayne Group Limited for Paxene(R) and revenues ...
Survival Boost for Head and Neck Cancers Oct 23, 2005
Ivanhoe, Patients also received chemotherapy with cisplatin (Platinol) and paclitaxel (Taxol, Onxol or Paxene) every day for two weeks for four cycles. ...
|
|
